Yingpinyapat Kittirat
Overview
Explore the profile of Yingpinyapat Kittirat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dokduang H, Katenak A, Kittirat Y, Tomacha J, Promraksa B, Taing L, et al.
Nat Prod Res
. 2025 Jan;
1-8.
PMID: 39862045
Powdered germinated Thai rice () is widely utilised as a dietary supplement to support health and prevent diseases. This study investigated the bioactive compound profile of water extracts from beverage...
2.
Armartmuntree N, Kittirat Y, Promraksa B, Loilome W, Dokduang H, Techasen A, et al.
PLoS One
. 2025 Jan;
20(1):e0317111.
PMID: 39820585
Cholangiocarcinoma (CCA) poses a significant healthcare challenge due to the limited effects of chemotherapeutic drugs. Natural products have gained widespread attention in cancer research according to their promising anti-cancer effects...
3.
Islam K, Balasubramanian B, Venkatraman S, Thummarati P, Tunganuntarat J, Phueakphud N, et al.
Sci Rep
. 2024 Sep;
14(1):21696.
PMID: 39289406
No abstract available.
4.
Islam K, Balasubramanian B, Venkatraman S, Thummarati P, Tunganuntarat J, Phueakphud N, et al.
Sci Rep
. 2023 Dec;
13(1):22598.
PMID: 38114514
A poor outcome for cholangiocarcinoma (CCA) patients is still a clinical challenge. CCA is typically recognized by the desmoplastic nature, which accounts for its malignancy. Among various extracellular matrix proteins,...
5.
Thongchot S, Ferraresi A, Vidoni C, Salwa A, Vallino L, Kittirat Y, et al.
Cancer Lett
. 2023 Dec;
582:216589.
PMID: 38097133
Cholangiocarcinoma (CCA), the malignant tumor of bile duct epithelial cells, is a relatively rare yet highly lethal cancer. In this work, we tested the ability of Resveratrol (RV) to prevent...
6.
Kulthawatsiri T, Kittirat Y, Phetcharaburanin J, Tomacha J, Promraksa B, Wangwiwatsin A, et al.
PeerJ
. 2023 Nov;
11:e16512.
PMID: 38025687
Background: Niclosamide is an oral anthelminthic drug that has been used for treating tapeworm infections. Its mechanism involves the disturbance of mitochondrial membrane potential that in turn inhibits oxidative phosphorylation...
7.
Phukhum P, Phetcharaburanin J, Chaleekarn K, Kittirat Y, Kulthawatsiri T, Namwat N, et al.
Sci Rep
. 2023 Feb;
13(1):3072.
PMID: 36810897
The three-dimensional multicellular spheroid (3D MCS) model has been employed in cholangiocarcinoma research as it generates 3D architecture and includes more physiological relevance with the multicellular arrangement. However, it is...
8.
Kittirat Y, Suksawat M, Thongchot S, Padthaisong S, Phetcharaburanin J, Wangwiwatsin A, et al.
Front Pharmacol
. 2022 Sep;
13:897368.
PMID: 36091805
Cancer-associated fibroblasts (CAFs) are the dominant component of the tumor microenvironment (TME) that can be beneficial to the generation and progression of cancer cells leading to chemotherapeutic failure several mechanisms....
9.
Worasith C, Kopolrat K, Pitaksakulrat O, Homwong C, Kittirat Y, Wongphutorn P, et al.
Am J Trop Med Hyg
. 2022 Mar;
PMID: 35344931
Infection by Opisthorchis viverrini causes significant health problems, including cholangiocarcinoma (CCA); thus control and elimination of this trematode is an important strategy for the reduction of CCA. Currently, urine and...
10.
Kittirat Y, Phetcharaburanin J, Promraksa B, Kulthawatsiri T, Wangwiwatsin A, Klanrit P, et al.
Front Public Health
. 2021 Dec;
9:766455.
PMID: 34950627
Pyrvinium pamoate (PP), an FDA-approved anthelmintic drug, has been validated as a highly potent anti-cancer agent and patented recently as a potential chemotherapeutic drug for various cancers. The aims of...